NEWS
“Brevetti+ 2022 – Patent Enhancement Project”
Project funded under the Brevetti+ measure with European Union funds – NextGenerationEU CLP: BRE0001526CUP: C19J23000310001 Project for the enhancement of patent no. 102020000016429, granted in Italy on August 5, 2022, titled:"METHOD FOR THE EVALUATION OF THE...
Utopia SIS and Pariter Partners invest in Lighthouse Biotech
Lighthouse Biotech aims to define new boundaries for oncology research through new liquid biopsy technologies The investment will be the first to be guaranteed by Medio Credito Centrale for over 80% Milan, December 29, 2021 – Utopia SIS, an investment company...
Utopia SIS and Pariter Partners invest in Lighthouse Biotech
Lighthouse Biotech aims to define new boundaries for oncology research through new liquid biopsy technologies The investment will be the first to be guaranteed by Medio Credito Centrale for over 80% Milan, December 29, 2021 – Utopia SIS, an investment company...
Rigenera: platform for the production of decellularized matrices for cardiac regeneration
DESCRIPTION The project is part of the most recent trends in regenerative medicine (whose goal is to regenerate, replace, or repair damaged tissues or organs), such as the decellularization of animal and human hearts. This means the removal of immunogenic elements,...
